We are live on !
Find out more
Brown Advisory Portfolio holdings
AUM
$64.6B
Turnover
14.74%
1-Year Est. Return
18.98%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
+18.98%
3 Year Est. Return
+84.85%
5 Year Est. Return
+98.36%
10 Year Est. Return
+536.38%
AUM
$29.1B
AUM Growth
+$628M
(+2.2%)
Cap. Flow
-$705M
Cap. Flow % of AUM
Cap. Flow %
-2.42%
Top 10 Holdings %
Top 10 Hldgs %
22.73%
Holding
1,138
New
91
Increased
498
Reduced
344
Closed
68
Avg Time Held
Equity + Options
2
years
Top 10 Avg Time Held
Equity + Options
1
year
Top 20 Avg Time Held
Equity + Options
1.7
years
Avg Time Held Equity only
2
years
Top 10 Avg Time Held Equity only
1
year
Top 20 Avg Time Held Equity only
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$407M |
| 2 |
DexCom
DXCM
|
+$326M |
| 3 |
Roper Technologies
ROP
|
+$288M |
| 4 |
PayPal
PYPL
|
+$238M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$498M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$448M |
| 3 |
Fastenal
FAST
|
+$296M |
| 4 |
Charles Schwab
SCHW
|
+$175M |
| 5 |
Amazon
AMZN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 14.04% |
| 4 | Consumer Discretionary | 12.34% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Visa
V
$767B
| $1.01B | 3.48% |
12,250,052
-598,214
| -5% | -$47.9M |
2013 Q2
13 quarters
|
|
2
Meta Platforms (Facebook)
META
$1.63T
| $836M | 2.87% |
6,517,805
+96,244
| +1% | +$11.9M |
2013 Q2
13 quarters
|
|
|
3
Amazon
AMZN
$2.63T
| $798M | 2.74% |
19,069,300
-2,754,320
| -13% | -$105M |
2013 Q2
13 quarters
|
|
4
Alphabet (Google) Class C
GOOG
$3.47T
| $639M | 2.2% |
16,442,240
-456,960
| -3% | -$17.4M |
2013 Q2
13 quarters
|
|
5
Starbucks
SBUX
$120B
| $600M | 2.06% |
11,089,098
-97,934
| -0.9% | -$5.48M |
2013 Q2
13 quarters
|
|
6
Danaher
DHR
$167B
| $591M | 2.03% |
8,498,498
-1,316,340
| -13% | -$93.3M |
2013 Q2
13 quarters
|
|
7
Intuitive Surgical
ISRG
$159B
| $557M | 1.91% |
6,914,916
-728,712
| -10% | -$55.8M |
2013 Q2
13 quarters
|
|
8
Costco
COST
$441B
| $533M | 1.83% |
3,492,657
-232,387
| -6% | -$37.6M |
2013 Q2
13 quarters
|
|
9
Ecolab
ECL
$84.3B
| $532M | 1.83% |
4,370,929
-258,666
| -6% | -$31.2M |
2013 Q2
13 quarters
|
|
10
Estee Lauder
EL
$39.4B
| $514M | 1.77% |
5,801,816
-57,452
| -1% | -$5.24M |
2013 Q2
13 quarters
|
|
11
NXP Semiconductors
NXPI
$67B
| $513M | 1.76% |
5,029,239
-43,811
| -0.9% | -$3.71M |
2014 Q4
7 quarters
|
|
12
Amphenol
APH
$202B
| $506M | 1.74% |
62,356,272
-4,275,888
| -6% | -$32.5M |
2013 Q2
13 quarters
|
|
13
Salesforce
CRM
$190B
| $488M | 1.68% |
6,836,742
-44,135
| -0.6% | -$3.44M |
2013 Q2
13 quarters
|
|
|
ALXN
14
DELISTED
Alexion Pharmaceuticals
ALXN
| $475M | 1.63% |
3,872,766
+825,135
| +27% | +$106M |
2015 Q1
6 quarters
|
|
15
Adobe
ADBE
$96.6B
| $468M | 1.61% |
4,310,474
+481,596
| +13% | +$48.3M |
2013 Q2
13 quarters
|
|
|
16
PayPal
PYPL
$47.3B
| $467M | 1.61% |
11,405,036
+6,202,145
| +119% | +$238M |
2015 Q3
4 quarters
|
|
|
N
17
DELISTED
Netsuite Inc
N
| $415M | 1.43% |
3,751,088
-231,670
| -6% | -$23.3M |
2013 Q2
13 quarters
|
|
18
TripAdvisor
TRIP
$1.08B
| $414M | 1.42% |
6,552,446
-456,522
| -7% | -$29.3M |
2014 Q4
7 quarters
|
|
|
MJN
19
DELISTED
Mead Johnson Nutrition Company
MJN
| $414M | 1.42% |
5,236,921
-59,836
| -1% | -$5.1M |
2013 Q2
13 quarters
|
|
20
Alphabet (Google) Class A
GOOGL
$3.49T
| $407M | 1.4% |
10,124,320
-2,437,260
| -19% | -$95.3M |
2015 Q4
3 quarters
|
|
|
21
Fortive
FTV
$19.6B
| $407M | 1.4% |
+12,666,674
| New | +$407M |
2016 Q3
0 quarters
|
|
22
Corpay
CPAY
$26.1B
| $398M | 1.37% |
2,293,423
-32,873
| -1% | -$5.27M |
2015 Q3
4 quarters
|
|
23
SBA Communications
SBAC
$19.6B
| $373M | 1.28% |
3,324,786
-86,460
| -3% | -$9.8M |
2013 Q2
13 quarters
|
|
24
Wabtec
WAB
$48.2B
| $365M | 1.26% |
4,472,601
-304,200
| -6% | -$22.3M |
2013 Q2
13 quarters
|
|
25
Genpact
G
$6.52B
| $337M | 1.16% |
14,052,085
-1,588,057
| -10% | -$39.3M |
2013 Q2
13 quarters
|
|
Similar funds
Brown Advisory's Q3 2016 Portfolio in Review
As of Q3 2016, Brown Advisory held 1,138 positions worth $29.1B, up 2.2% from $28.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Brown Advisory's Q3 2016 filing shows 91 new, 498 increased, 344 reduced and 68 closed positions. Its largest new stake was Fortive: 12,666,674 shares worth $407M. The largest sale was Bristol-Myers Squibb, an estimated $498M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q3 2016 buy was Fortive: 12,666,674 shares worth $407M.
- Brown Advisory added most to DexCom in Q3 2016, an estimated $326M increase.
- Brown Advisory's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $498M.
- Brown Advisory fully exited DIAMOND RESORTS INTL, INC in Q3 2016, selling an estimated $53.1M.
- Brown Advisory's ten largest holdings make up 23% of its $29.1B portfolio in Q3 2016.
- Brown Advisory opened 91 new positions and closed 68 in Q3 2016.
- Brown Advisory's portfolio value rose 2.2% quarter-over-quarter to $29.1B.
Based on Brown Advisory's 13F filing for Q3 2016, filed 14 Nov 2016.